Cardiovascular Risk Completed Phase 4 Trials for Rosuvastatin (DB01098)

Also known as: Cardiovascular Risk Factors / Cardiovascular Risk Factor / Cardiovascular Disease (CVD) Risk Factors / Cardiovascular Disease Risk Factors / Risk Factors Cardiovascular Disease / Cardiovascular Disease Risk / Cardiovascular Diseases Risk / Cardiovascular (CV) Risk / Cardiovascular Risks

IndicationStatusPhase
DBCOND0039927 (Cardiovascular Risk)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01490398Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity ReserveTreatment